| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 9 | -190K | 100% | $12.30 | -$2.33M |
| Net | -9 | -190K | -100% | -$2.33M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Eric M. Dube | CHIEF EXECUTIVE OFFICER, Director | $4.17M | -$480K | -10.3% | Sep 5, 2024 |
| Steve Aselage | Director | $1.32M | May 11, 2022 | ||
| Peter Heerma | Chief Commercial Officer | $1.24M | -$75.2K | -5.7% | Sep 5, 2024 |
| Jeffrey Meckler | Director | $1.14M | -$562K | -33.1% | Sep 30, 2024 |
| Sandra Calvin | Svp, Chief Accounting Officer | $1.01M | -$254K | -20.1% | Nov 25, 2024 |
| William E. Rote | Senior Vice President, R&D | $973K | -$111K | -10.2% | Sep 5, 2024 |
| Elizabeth E. Reed | Svp, Gc & Corporate Secretary | $906K | -$111K | -10.9% | Sep 5, 2024 |
| Christopher R. Cline | Chief Financial Officer | $859K | -$74.2K | -7.95% | Sep 5, 2024 |
| Jula Inrig | Chief Medical Officer | $804K | -$76.3K | -8.67% | Sep 10, 2024 |
| Gary A. Lyons | Director | $773K | -$589K | -43.3% | Oct 4, 2024 |
| Noah L. Rosenberg | Chief Medical Officer | $427K | Aug 13, 2021 | ||
| Timothy Coughlin | Director | $330K | May 8, 2024 | ||
| Laura Clague | Chief Financial Officer | $319K | May 10, 2022 | ||
| Roy D. Baynes | Director | $209K | May 8, 2024 | ||
| John A. Orwin | Director | $195K | May 8, 2024 | ||
| Ron Squarer | Director | $195K | May 8, 2024 | ||
| Sandra Poole | Director | $158K | May 8, 2024 | ||
| Suzanne Louise Bruhn | Director | $150K | May 8, 2024 | ||
| Brinkley Ruth Williams | Director | $130K | May 8, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|